Hemochromatosis and Iron Overload Screening Study (HEIRS)

This study has been completed.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
First received: May 25, 2000
Last updated: April 13, 2016
Last verified: April 2009
To determine the prevalence, genetic and environmental determinants, and potential clinical, personal, and societal impact of iron overload and hereditary hemochromatosis, in a multi-center, multiethnic, primary care-based sample of 100,000 adults. The study is conducted by the Division of Epidemiology and Clinical Applications of the NHLBI, the Division of Blood Diseases and Resources of the NHLBI, and the Ethical, Legal, and Social Implications (ELSI) Research Program of the NHGRI.

Blood Disease
Iron Overload

Study Type: Observational

Resource links provided by NLM:

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: January 2000
Study Completion Date: January 2006
Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   25 Years to 100 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005541

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigator: Ronald Acton University of Alabama at Birmingham
Investigator: Paul Adams London Health Sciences Centre
Investigator: John Eckfeldt University of Minnesota - Clinical and Translational Science Institute
Investigator: Victor Gordeuk Howard University
Investigator: Emily Harris Kaiser Foundation Research Institute
Investigator: Christine McLaren University of California
Investigator: David Reboussin Wake Forest University
  More Information

ClinicalTrials.gov Identifier: NCT00005541     History of Changes
Other Study ID Numbers: 5083 
Study First Received: May 25, 2000
Last Updated: April 13, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hematologic Diseases
Iron Overload
Genetic Diseases, Inborn
Iron Metabolism Disorders
Metabolic Diseases
Metabolism, Inborn Errors
Metal Metabolism, Inborn Errors

ClinicalTrials.gov processed this record on May 22, 2016